Ibalizumab vs Sitagliptin

## Ibalizumab vs Sitagliptin: Overview

This comparison examines the pharmacological differences between **Ibalizumab** and **Sitagliptin**.

## Mechanism of Action

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Ibalizumab — N/A; Sitagliptin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Ibalizumab — N/A; Sitagliptin — C16H15F6N5O.

**Molecular Weight**: Ibalizumab — N/A; Sitagliptin — 407.3140 g/mol.

**Type**: Ibalizumab — Antibody; Sitagliptin — Small molecule.